This was fun to read. It could be interesting to hear about deep-dives in each of these areas to find out what determines success vs failure. Obviously factors like P3 trial passage can drive success for pharmaceutical biotechs, but beyond an IP moat and PMF, what really separates the winners from losers? What does this suggest the next generation of platform biotech entrepreneurs should do?
Thanks, interesting post, but Schrodinger and Abcellear have pipelines, so they are not "just" service companies, certainly. Also, Cyclica was acquired a couple years ago by Recursion.
Great post, But what would you consider a fund raising strategy for a biologics platform company ( platform already running) that needs just 7-10 M for setting up labs, and another 10-14 M for optimising say 2-3 candidates. The problem is that you need at least 24 M to come out with a product, How would you approach investors asking for a 24 M at one go, or asking 7-10 to set up labs etc. Any thoughts?
http://submarinecatalyst.com Quantitative PDUFA breakdowns before the FDA decides. Built solo.
Thanks guys, this was helpful. Keep up the good work.
This was fun to read. It could be interesting to hear about deep-dives in each of these areas to find out what determines success vs failure. Obviously factors like P3 trial passage can drive success for pharmaceutical biotechs, but beyond an IP moat and PMF, what really separates the winners from losers? What does this suggest the next generation of platform biotech entrepreneurs should do?
Following, excited to hear more!
Thanks, interesting post, but Schrodinger and Abcellear have pipelines, so they are not "just" service companies, certainly. Also, Cyclica was acquired a couple years ago by Recursion.
https://www.baybridgebio.com/blog/platform-underperform.html
Great post, But what would you consider a fund raising strategy for a biologics platform company ( platform already running) that needs just 7-10 M for setting up labs, and another 10-14 M for optimising say 2-3 candidates. The problem is that you need at least 24 M to come out with a product, How would you approach investors asking for a 24 M at one go, or asking 7-10 to set up labs etc. Any thoughts?